Table 1.
Time |
Two-way ANOVA |
||||||
---|---|---|---|---|---|---|---|
Baseline | CCR | 0 Hour: Infusion | F-value | P-value | |||
Endothelin (fmol/mL) | |||||||
Treatment | Vehicle | 2.8 ± 0.4 | 3.3 ± 0.4 | 2.9 ± 0.4 | Time | 1.02 | 0.36 |
0.1 mg/kg | 3.0 ± 0.5 | 3.9 ± 0.6 | 3.8 ± 1.1 | Treatment | 4.15 | 0.04 | |
0.5 mg/kg | 2.5 ± 0.4 | 3.7 ± 0.5 | 4.4 ± 1.0 | ||||
1 mg/kg | 4.1 ± 0.6 | 5.1 ± 0.9 | 4.1 ± 1.1 | ||||
2 mg/kg | 3.3 ± 0.7 | 4.9 ± 1.1 | 5.8 ± 1.4 | ||||
Interleukin 6 (pg/mL) | |||||||
Treatment | Vehicle | 8.0 ± 2.2 | 46.4 ± 26.1 | 88.1 ± 47.2 | Time | 9.80 | <0.01 |
0.1 mg/kg | 9.1 ± 2.3 | 39.2 ± 9.0 | 80.4 ± 20.6 | Treatment | 0.05 | 0.83 | |
0.5 mg/kg | 8.5 ± 2.1 | 49.6 ± 11.0 | 79.0 ± 16.9 | ||||
1 mg/kg | 10.3 ± 1.8 | 40.4 ± 15.6 | 95.2 ± 44.0 | ||||
2 mg/kg | 8.4 ± 2.4 | 39.3 ± 10.5 | 71.2 ± 17.9 | ||||
Interleukin 10 (pg/mL) | |||||||
Treatment | Vehicle | 3.0 ± 0.9 | 17.1 ± 8.2 | 18.0 ± 8.1 | Time | 2.04 | 0.13 |
0.1 mg/kg | 4.0 ± 1.8 | 30.7 ± 20.5 | 36.5 ± 24.5 | Treatment | 0.03 | 0.86 | |
0.5 mg/kg | 3.2 ± 0.7 | 13.2 ± 7.2 | 14.2 ± 6.4 | ||||
1 mg/kg | 5.2 ± 1.1 | 10.7 ± 4.3 | 26.4 ± 12.1 | ||||
2 mg/kg | 3.6 ± 0.8 | 7.0 ± 1.8 | 6.4 ± 1.3 | ||||
Tumor Necrosis Factor (TNF:pg/mL) | |||||||
Treatment | Vehicle | 4.8 ± 1.8 | 0.5 ± 0.1 | 0.7 ± 0.1 | Time | 0.03 | 0.97 |
0.1 mg/kg | 2.9 ± 0.8 | 1.9 ± 0.6 | 2.3 ± 0.7 | Treatment | 1.79 | 0.18 | |
0.5 mg/kg | 3.8 ± 1.0 | 1.2 ± 0.3 | 0.9 ± 0.2 | ||||
1 mg/kg | 7.3 ± 1.9 | 15.5 ± 8.3 | 27.2 ± 15.1 | ||||
2 mg/kg | 4.6 ± 1.9 | 5.6 ± 3.2 | 4.02 ± 2.1 | ||||
TNF Receptor I (ng/mL) | |||||||
Treatment | Vehicle | 2.73 ± 1.35 | 2.34 ± 0.30 | 5.00 ± 1.01 | Time | 13.62 | <0.01 |
0.1 mg/kg | 2.16 ± 0.71 | 2.67 ± 0.16 | 4.02 ± 0.23 | Treatment | 0.10 | 0.75 | |
0.5 mg/kg | 2.12 ± 0.60 | 3.18 ± 0.54 | 4.86 ± 0.55 | ||||
1 mg/kg | 2.65 ± 0.84 | 3.54 ± 0.69 | 7.14 ± 1.26 | ||||
2 mg/kg | 1.80 ± 0.28 | 2.59 ± 0.11 | 5.24 ± 0.71 | ||||
TNF Receptor II (ng/mL) | |||||||
Treatment | Vehicle | 0.53 ± 0.08 | 0.59 ± 0.05 | 1.03 ± 0.18 | Time | 11.22 | <0.01 |
0.1 mg/kg | 0.46 ± 0.09 | 0.62 ± 0.07 | 0.85 ± 0.05 | Treatment | 1.01 | 0.32 | |
0.5 mg/kg | 0.53 ± 0.05 | 1.02 ± 0.29 | 1.32 ± 0.22 | ||||
1 mg/kg | 0.60 ± 0.13 | 0.73 ± 0.13 | 1.35 ± 0.27 | ||||
2 mg/kg | 0.50 ± 0.06 | 0.72 ± 0.07 | 1.11 ± 0.15 |
0 Hour: Separation from cardiopulmonary bypass and time of infusion. Treatment indicates patient randomized to vehicle or ET-AR Antagonist. ANOVA: analysis of variance. Vehicle: n = 9, 0.1 mg/kg: n=9, 0.5 mg/kg: n=9, 1 mg/kg: n=9, 2 mg/kg: n=8.